Zynerba Pharmaceuticals Inc
(NASDAQ : ZYNE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
3.44%16.5414.1%$318.35m
SHPGShire PLC Sponsored ADR
3.42%149.780.4%$211.23m
PRGOPerrigo Co. Plc
0.01%86.766.6%$134.94m
MNKMallinckrodt Plc
-0.09%21.3718.5%$118.92m
SAGESAGE Therapeutics, Inc.
6.12%95.4410.9%$106.75m
JAZZJazz Pharmaceuticals Plc
0.62%138.042.2%$77.00m
ENDPEndo International Plc
0.79%7.638.9%$67.47m
ICPTIntercept Pharmaceuticals, Inc.
0.71%62.2422.0%$50.61m
UTHRUnited Therapeutics Corporation
0.00%125.4114.5%$49.65m
PCRXPacira Pharmaceuticals, Inc.
4.34%44.5010.7%$49.15m
ADMSAdamas Pharmaceuticals, Inc.
8.36%33.5916.9%$42.85m
MDCOMedicines Company
0.71%31.4022.1%$39.84m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.91%126.387.6%$39.41m
ICLRICON Plc
0.77%118.354.1%$38.03m
PTLAPortola Pharmaceuticals, Inc.
0.93%51.277.8%$34.80m

Company Profile

Zynerba Pharmaceuticals, Inc. engages in the research and development of drugs. Its clinical programs include synthetic cannabinoid therapeutics and patch and gel for transdermal delivery. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.